Literature DB >> 22532694

Two crucial early steps in RNA synthesis by the hepatitis C virus polymerase involve a dual role of residue 405.

Nathalie Scrima1, Célia Caillet-Saguy, Michel Ventura, Déborah Harrus, Thérèse Astier-Gin, Stéphane Bressanelli.   

Abstract

The hepatitis C virus (HCV) NS5B protein is an RNA-dependent RNA polymerase essential for replication of the viral RNA genome. In vitro and presumably in vivo, NS5B initiates RNA synthesis by a de novo mechanism and then processively copies the whole RNA template. Dissections of de novo RNA synthesis by genotype 1 NS5B proteins previously established that there are two successive crucial steps in de novo initiation. The first is dinucleotide formation, which requires a closed conformation, and the second is the transition to elongation, which requires an opening of NS5B. We also recently published a combined structural and functional analysis of genotype 2 HCV-NS5B proteins (of strains JFH1 and J6) that established residue 405 as a key element in de novo RNA synthesis (P. Simister et al., J. Virol. 83:11926-11939, 2009; M. Schmitt et al., J. Virol 85:2565-2581, 2011). We hypothesized that this residue stabilizes a particularly closed conformation conducive to dinucleotide formation. Here we report similar in vitro dissections of de novo synthesis for J6 and JFH1 NS5B proteins, as well as for mutants at position 405 of several genotype 1 and 2 strains. Our results show that an isoleucine at position 405 can promote both dinucleotide formation and the transition to elongation. New structural results highlight a molecular switch of position 405 with long-range effects, resolving the implied paradox of how the same residue can successively favor both the closed conformation of the dinucleotide formation step and the opening necessary to the transition step.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22532694      PMCID: PMC3416344          DOI: 10.1128/JVI.00459-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Only a small fraction of purified hepatitis C RNA-dependent RNA polymerase is catalytically competent: implications for viral replication and in vitro assays.

Authors:  S S Carroll; V Sardana; Z Yang; A R Jacobs; C Mizenko; D Hall; L Hill; J Zugay-Murphy; L C Kuo
Journal:  Biochemistry       Date:  2000-07-18       Impact factor: 3.162

2.  A summary of the 18th International Symposium on Hepatitis C Virus and Related Viruses.

Authors:  Stephen J Polyak; Chihiro Morishima; John D Scott; Pablo Gastaminza; Andrea Cox; Evaldo Stanislau Affonso de Araújo; Martin R Higgs; Yueh-Ming Loo; Lucy Golden-Mason; Brett D Lindenbach; Thomas F Baumert; Glenn Randall; Michael Gale
Journal:  Gastroenterology       Date:  2012-01       Impact factor: 22.682

3.  Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo.

Authors:  M Yanagi; M St Claire; M Shapiro; S U Emerson; R H Purcell; J Bukh
Journal:  Virology       Date:  1998-04-25       Impact factor: 3.616

4.  A mechanism for initiating RNA-dependent RNA polymerization.

Authors:  S J Butcher; J M Grimes; E V Makeyev; D H Bamford; D I Stuart
Journal:  Nature       Date:  2001-03-08       Impact factor: 49.962

5.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.

Authors:  Takaji Wakita; Thomas Pietschmann; Takanobu Kato; Tomoko Date; Michiko Miyamoto; Zijiang Zhao; Krishna Murthy; Anja Habermann; Hans-Georg Kräusslich; Masashi Mizokami; Ralf Bartenschlager; T Jake Liang
Journal:  Nat Med       Date:  2005-06-12       Impact factor: 53.440

6.  Robust hepatitis C virus infection in vitro.

Authors:  Jin Zhong; Pablo Gastaminza; Guofeng Cheng; Sharookh Kapadia; Takanobu Kato; Dennis R Burton; Stefan F Wieland; Susan L Uprichard; Takaji Wakita; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

7.  The essential role of C-terminal residues in regulating the activity of hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Tsuyoshi Adachi; Hideo Ago; Noriyuki Habuka; Kayo Okuda; Masakazu Komatsu; Satoru Ikeda; Kimio Yatsunami
Journal:  Biochim Biophys Acta       Date:  2002-11-19

8.  PHENIX: a comprehensive Python-based system for macromolecular structure solution.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Ian W Davis; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Gary J Kapral; Ralf W Grosse-Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

9.  An objective assessment of conformational variability in complexes of hepatitis C virus polymerase with non-nucleoside inhibitors.

Authors:  Célia Caillet-Saguy; Philip C Simister; Stéphane Bressanelli
Journal:  J Mol Biol       Date:  2011-10-08       Impact factor: 5.469

10.  euHCVdb: the European hepatitis C virus database.

Authors:  Christophe Combet; Nicolas Garnier; Céline Charavay; Delphine Grando; Daniel Crisan; Julien Lopez; Alexandre Dehne-Garcia; Christophe Geourjon; Emmanuel Bettler; Chantal Hulo; Philippe Le Mercier; Ralf Bartenschlager; Helmut Diepolder; Darius Moradpour; Jean-Michel Pawlotsky; Charles M Rice; Christian Trépo; François Penin; Gilbert Deléage
Journal:  Nucleic Acids Res       Date:  2006-11-16       Impact factor: 16.971

View more
  15 in total

1.  Construction of a chimeric hepatitis C virus replicon based on a strain isolated from a chronic hepatitis C patient.

Authors:  Huang Cao; Wandi Zhu; Qingxia Han; Rongjuan Pei; Xinwen Chen
Journal:  Virol Sin       Date:  2014-01-20       Impact factor: 4.327

2.  Viral Capsid and Polymerase in Reoviridae.

Authors:  Hongrong Liu; Lingpeng Cheng
Journal:  Subcell Biochem       Date:  2022

3.  Efficiency of incorporation and chain termination determines the inhibition potency of 2'-modified nucleotide analogs against hepatitis C virus polymerase.

Authors:  Amy Fung; Zhinan Jin; Natalia Dyatkina; Guangyi Wang; Leo Beigelman; Jerome Deval
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

4.  Molecular and structural basis for the roles of hepatitis C virus polymerase NS5B amino acids 15, 223, and 321 in viral replication and drug resistance.

Authors:  Angela M Lam; Thomas E Edwards; Ralph T Mosley; Eisuke Murakami; Shalini Bansal; Christopher Lugo; Haiying Bao; Michael J Otto; Michael J Sofia; Phillip A Furman
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

5.  Structural and regulatory elements of HCV NS5B polymerase--β-loop and C-terminal tail--are required for activity of allosteric thumb site II inhibitors.

Authors:  Sarah E Boyce; Neeraj Tirunagari; Anita Niedziela-Majka; Jason Perry; Melanie Wong; Elaine Kan; Leanna Lagpacan; Ona Barauskas; Magdeleine Hung; Martijn Fenaux; Todd Appleby; William J Watkins; Uli Schmitz; Roman Sakowicz
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

Review 6.  Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance.

Authors:  Auda A Eltahla; Fabio Luciani; Peter A White; Andrew R Lloyd; Rowena A Bull
Journal:  Viruses       Date:  2015-09-29       Impact factor: 5.048

7.  The hepatitis C virus core protein can modulate RNA-dependent RNA synthesis by the 2a polymerase.

Authors:  Y Wen; C Cheng Kao
Journal:  Virus Res       Date:  2014-05-26       Impact factor: 3.303

8.  NMR reveals the intrinsically disordered domain 2 of NS5A protein as an allosteric regulator of the hepatitis C virus RNA polymerase NS5B.

Authors:  Luiza M Bessa; Hélène Launay; Marie Dujardin; François-Xavier Cantrelle; Guy Lippens; Isabelle Landrieu; Robert Schneider; Xavier Hanoulle
Journal:  J Biol Chem       Date:  2017-09-14       Impact factor: 5.486

9.  Cross-genotypic examination of hepatitis C virus polymerase inhibitors reveals a novel mechanism of action for thumb binders.

Authors:  Auda A Eltahla; Enoch Tay; Mark W Douglas; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2014-09-22       Impact factor: 5.938

10.  The methyltransferase domain of dengue virus protein NS5 ensures efficient RNA synthesis initiation and elongation by the polymerase domain.

Authors:  Supanee Potisopon; Stéphane Priet; Axelle Collet; Etienne Decroly; Bruno Canard; Barbara Selisko
Journal:  Nucleic Acids Res       Date:  2014-09-10       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.